Paper Details

  1. Home
  2. Paper Details

Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group.

Author: KnightA, NewhouseM, NewmanK, WangS

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Flunisolide administered via AeroChamber and budesonide administered via Turbuhaler demonstrated similar efficacy and safety in treating moderate asthma.
Paper Details　
Original Abstract of the Article :
BACKGROUND: There is a limited body of evidence comparing the clinical effects of different inhaled corticosteroids in the treatment of asthma. This study compared the safety and efficacy of inhaled flunisolide and budesonide, both with unique delivery systems that may affect clinical response. OBJ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s1081-1206(10)62779-2

データ提供：米国国立医学図書館（NLM）

Inhaled Corticosteroids for Asthma: A Comparison of Flunisolide and Budesonide

This research investigates the efficacy and safety of two inhaled corticosteroids, flunisolide and budesonide, for the treatment of moderate asthma. The study compares the clinical effects of these medications when administered via different delivery systems, AeroChamber for flunisolide and Turbuhaler for budesonide. The study design included a 2-week run-in period followed by a 6-week treatment period. The results indicate that both flunisolide and budesonide demonstrate similar efficacy and safety profiles in the treatment of moderate asthma, regardless of the delivery system used.

The Desert of Asthma Treatment: Navigating Effective Options

The study's findings provide valuable information for healthcare providers and patients seeking effective treatment for moderate asthma. The study's conclusion that both flunisolide and budesonide, when administered via their respective delivery systems, are equally effective and safe, expands the range of treatment options available. This research highlights the importance of individualizing treatment based on patient preferences and needs.

Navigating the Sands of Asthma Management

Navigating the sands of asthma management requires a careful balance between medication effectiveness and safety. This research provides valuable insights into the efficacy and safety of two inhaled corticosteroids, flunisolide and budesonide, offering patients and their healthcare providers a greater understanding of treatment options. Remember, the desert of asthma management can be navigated with a watchful eye, open communication with your healthcare provider, and a commitment to receiving the best possible care.

Dr.Camel's Conclusion

This research sheds light on the effectiveness and safety of two inhaled corticosteroids, flunisolide and budesonide, for the treatment of moderate asthma. The study's findings suggest that both medications, when administered via their respective delivery systems, are equally effective and safe, offering patients and their healthcare providers a broader range of treatment options.

Date :
  1. Date Completed 2000-04-27
  2. Date Revised 2021-09-01
Further Info :

Pubmed ID

10752915

DOI: Digital Object Identifier

10.1016/s1081-1206(10)62779-2

Related Literature

Article Analysis
・Effects of budesonide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.